We bring together talent and expertise from across the University of Minnesota to use stem cell biology to advance regenerative medicine therapies for devastating disorders and to provide education and training for the stem cell scientists of tomorrow.
Our Education Programs
The bioscience and medical industries and academic research programs need intelligent, engaged, well-trained talent to fill jobs in the rapidly expanding field of regenerative medicine. The Stem Cell Institute prepares students who are ready to meet this need and who are eager to move the next generation of research forward. Learn more about our graduate programs:
In the News
A blood washing device invented by IEM Executive Committee Member Dr. Allison Hubel, Professor of Mechanical Engineering, and Director of the IEM-affiliated Biopreservation Core Resource (BioCoR), was featured by Twin Cities Business. The automated system cleanses from thawed blood glycerol preservatives, which are added to blood prior to its freezing for storage, and it does so more efficiently and safely than does a centrifuge, which has been the standard type of equipment used for this process and which requires more time and labor to use and results in high cell losses. Dr. Hubel's device could ultimately help to make large strategic reserves available from blood produced from stem cells, during emergencies when insufficient quantities of donated blood are available - something which is not as possible with centrifuges. The device took a big step toward this future with a $223,000 Phase I NIH SBIR grant awarded in September to the start-up company seeking to commercialize it, Headwaters Innovation Inc., led by a successful local entrepreneur.
IEM members Drs. Richard W. Bianco, Associate Professor of Surgery and Program Director of Experimental Surgical Services, and Brenda M. Ogle, Associate Professor of Biomedical Engineering have been elected to the 2017 Class of American Institute for Medical and Biological Engineering (AIMBE) Fellows. Drs. Bianco and Ogle will join the AIMBE College of Fellows, which consists of approximately "1,500 individuals who are the outstanding bioengineers in academia, industry and government. These leaders in the field have distinguished themselves through their contributions in research, industrial practice and/or education." Each will be inducted on March 20th at AIMBE's Annual Even in Washington, D.C.
Several IEM Members will help to lead a component of the recently-announced National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), a consortium of companies, state governments and academic institutions that seeks to advance the rapidly-growing biopharmaceutical industry with innovative production processes and both the creation and training of its future workforce. The institute will be supported by what is expected to be more than $200 Million of public-private partnership funding including a $70 Million 5-year grant from the U.S. Department of Commerce.
The University of Minnesota component's leadership team will include IEM Members Drs. Samira M. Azarin, Assistant Professor of Chemical Engineering and Materials Science; Vadim J. Gurvich, Research Associate Professor of Medicinal Chemistry; Wei-Shou Hu, Professor of Chemical Engineering and Materials Science; David H. McKenna, Jr., Professor of Lab Medicine and Pathology; and Jakub Tolar, Professor of Pediatrics, Director of the Stem Cell Institute and Executive Vice Dean of the Medical School.
The promise of regenerative medicine is real, even if there are currently clinics advertising unproven and unregulated therapies. Minnesota is focused on developing approved and effective treatments. This article explains why this is so important.
Weekly Research Conference
Wednesday, January 25, 2017 - 4:00pm
HSC based gene therapy approaches for LSDs
Alessandra Biffi, MD
Associate Professor of Pediatrics
Director, Gene Therapy Program
Wednesday, February 1, 2017 - 4:00pm
Department of Pediatrics
Division of Blood and Marrow Transplantation
University of Minnesota
Wednesday, February 8, 2017 - 4:00pm
3D Printing of Extracellular Matrix proteins for Cardiac Repair